利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

10 条记录 (耗时 0.052 秒)

    Heteroaryl substituted benzoxazoles
    1.
    发明授权
    Heteroaryl substituted benzoxazoles 失效
    杂芳基取代的苯并恶唑

    公开(公告)号：US07670591B2

    公开(公告)日：2010-03-02

    申请号：US11763151

    申请日：2007-06-14

    申请人： Jonas Malmstrom ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Britt-Marie Swahn ,  David Wensbo

    发明人： Jonas Malmstrom ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Britt-Marie Swahn ,  David Wensbo

    IPC分类号： A61K51/04 ,  A61K31/443 ,  C07D413/04

    CPC分类号： C07D413/04

    摘要： The present invention relates to novel heteroaryl substituted benzoxazole derivatives and therapeutic uses for such compounds, having the structural formula (Ia) below: and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel heteroaryl substituted benzoxazole derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measuring clinical efficacy of Alzheimer's disease therapeutic agents.

    摘要翻译： 本发明涉及新颖的杂芳基取代的苯并恶唑衍生物和具有以下结构式（Ia）的化合物及其药学上可接受的盐，组合物和使用方法的治疗用途。 此外，本发明涉及适用于在活体患者中成像淀粉样蛋白沉积物的新型杂芳基取代的苯并恶唑衍生物，其组合物，使用方法和制备此类化合物的方法。 更具体地说，本发明涉及一种在体内淀粉样蛋白沉积物在体内成像以使阿尔茨海默病的止血诊断成为可能并测量阿尔茨海默病治疗剂的临床疗效的方法。

    Novel Heteroaryl Substituted Benzoxazoles
    2.
    发明申请
    Novel Heteroaryl Substituted Benzoxazoles 失效
    新型杂芳基取代苯并恶唑

    公开(公告)号：US20080027051A1

    公开(公告)日：2008-01-31

    申请号：US11763151

    申请日：2007-06-14

    申请人： Jonas Malmstrom ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Britt-Marie Swahn ,  David Wensbo

    发明人： Jonas Malmstrom ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Britt-Marie Swahn ,  David Wensbo

    IPC分类号： A61K31/443 ,  A61K31/506 ,  A61K31/5377 ,  A61P25/28 ,  A61P3/00 ,  C07D239/28 ,  C07D413/04 ,  C07D413/14

    CPC分类号： C07D413/04

    摘要： The present invention relates to novel heteroaryl substituted benzoxazole derivatives and therapeutic uses for such compounds, having the structural formula (Ia) below: and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel heteroaryl substituted benzoxazole derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measureing clinical efficacy of Alzheimer's disease therapeutic agents.

    摘要翻译： 本发明涉及新颖的杂芳基取代的苯并恶唑衍生物和具有以下结构式（Ia）的化合物及其药学上可接受的盐，组合物和使用方法的治疗用途。 此外，本发明涉及适用于在活体患者中成像淀粉样蛋白沉积物的新型杂芳基取代的苯并恶唑衍生物，其组合物，使用方法和制备此类化合物的方法。 更具体地说，本发明涉及在体内淀粉样蛋白沉积物在体内成像以使阿尔茨海默病的抗原异常诊断以及阿尔茨海默病治疗剂的临床疗效的测定方法。

    Heteroaryl substituted benzothiazoles
    3.
    发明授权
    Heteroaryl substituted benzothiazoles 失效
    杂芳基取代的苯并噻唑

    公开(公告)号：US08163928B2

    公开(公告)日：2012-04-24

    申请号：US12162255

    申请日：2007-01-25

    申请人： Ylva Gravenfors ,  Catrin Jonasson ,  Jonas Malmstrom ,  Gunnar Nordvall ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Peter Strom ,  David Wensbo

    发明人： Ylva Gravenfors ,  Catrin Jonasson ,  Jonas Malmstrom ,  Gunnar Nordvall ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Peter Strom ,  David Wensbo

    IPC分类号： A61K51/00 ,  A61K51/04

    CPC分类号： C07D417/04 ,  C07B59/002 ,  C07D513/04

    摘要： The present invention relates to novel heteroaryl substituted benzothiazole derivatives, precursors thereof, and therapeutic uses for such compounds, having the structural formula (I) below: [Chemical formula should be inserted here. Please see paper copy] and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel heteroaryl substituted benzothiazole derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measuring clinical efficacy of Alzheimer's disease therapeutic agents.

    摘要翻译： 本发明涉及新颖的杂芳基取代的苯并噻唑衍生物，其前体，以及具有以下结构式（I）的化合物的治疗用途：[化学式应在此插入。 请参阅纸本]及其药学上可接受的盐，组合物和使用方法。 此外，本发明涉及适用于在活体患者中成像淀粉样蛋白沉积物的新型杂芳基取代的苯并噻唑衍生物，其组合物，使用方法和制备此类化合物的方法。 更具体地说，本发明涉及一种在体内淀粉样蛋白沉积物在体内成像以使阿尔茨海默病的止血诊断成为可能并测量阿尔茨海默病治疗剂的临床疗效的方法。

    Heteroaryl substituted benzothiazoles
    4.
    发明授权
    Heteroaryl substituted benzothiazoles 有权
    杂芳基取代的苯并噻唑

    公开(公告)号：US08957215B2

    公开(公告)日：2015-02-17

    申请号：US13453579

    申请日：2012-04-23

    申请人： Ylva Gravenfors ,  Catrin Jonasson ,  Jonas Malmstrom ,  Gunnar Nordvall ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Peter Strom ,  David Wensbo

    发明人： Ylva Gravenfors ,  Catrin Jonasson ,  Jonas Malmstrom ,  Gunnar Nordvall ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Peter Strom ,  David Wensbo

    IPC分类号： C07D417/04 ,  C07D417/14 ,  C07B59/00 ,  C07D513/04

    CPC分类号： C07D417/04 ,  C07B59/002 ,  C07D513/04

    摘要： The present invention relates to novel heteroaryl substituted benzothiazole derivatives, precursors thereof, and therapeutic uses for such compounds, having the structural formula (I) below: and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel heteroaryl substituted benzothiazole derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measuring clinical efficacy of Alzheimer's disease therapeutic agents.

    摘要翻译： 本发明涉及新颖的杂芳基取代的苯并噻唑衍生物，其前体，以及具有以下结构式（I）的化合物及其药学上可接受的盐，组合物和使用方法的治疗用途。 此外，本发明涉及适用于在活体患者中成像淀粉样蛋白沉积物的新型杂芳基取代的苯并噻唑衍生物，其组合物，使用方法和制备此类化合物的方法。 更具体地说，本发明涉及一种在体内淀粉样蛋白沉积物在体内成像以使阿尔茨海默病的止血诊断成为可能并测量阿尔茨海默病治疗剂的临床疗效的方法。

    Novel Heteroaryl Substituted Benzothiazoles
    5.
    发明申请
    Novel Heteroaryl Substituted Benzothiazoles 失效
    新型杂芳基取代苯并噻唑

    公开(公告)号：US20090028787A1

    公开(公告)日：2009-01-29

    申请号：US12162255

    申请日：2007-01-25

    申请人： Ylva Gravenfors ,  Catrin Jonasson ,  Jonas Malmstrom ,  Gunnar Nordvall ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Peter Strom ,  David Wensbo

    发明人： Ylva Gravenfors ,  Catrin Jonasson ,  Jonas Malmstrom ,  Gunnar Nordvall ,  David Pyring ,  Can Slivo ,  Daniel Sohn ,  Peter Strom ,  David Wensbo

    IPC分类号： A61K31/496 ,  C07D417/14 ,  C07D417/04 ,  A61K31/5377 ,  A61P25/28 ,  A61K49/00 ,  A61K31/4439 ,  C07D413/14

    CPC分类号： C07D417/04 ,  C07B59/002 ,  C07D513/04

    摘要： The present invention relates to novel heteroaryl substituted benzothiazole derivatives, precursors thereof, and therapeutic uses for such compounds, having the structural formula (I) below: [Chemical formula should be inserted here. Please see paper copy] and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel heteroaryl substituted benzothiazole derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measuring clinical efficacy of Alzheimer's disease therapeutic agents.

    摘要翻译： 本发明涉及新颖的杂芳基取代的苯并噻唑衍生物，其前体，以及具有以下结构式（I）的化合物的治疗用途：[化学式应在此插入。 请参阅纸本]及其药学上可接受的盐，组合物和使用方法。 此外，本发明涉及适用于在活体患者中成像淀粉样蛋白沉积物的新型杂芳基取代的苯并噻唑衍生物，其组合物，使用方法和制备此类化合物的方法。 更具体地说，本发明涉及一种在体内淀粉样蛋白沉积物在体内成像以使阿尔茨海默病的止血诊断成为可能并测量阿尔茨海默病治疗剂的临床疗效的方法。

    Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives
    6.
    发明申请
    Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives 审中-公开
    新型杂芳基取代的咪唑并[1,2-A]吡啶衍生物

    公开(公告)号：US20100092385A1

    公开(公告)日：2010-04-15

    申请号：US12524019

    申请日：2008-01-21

    申请人： Michaela Vallin ,  Jonas Malmstrom ,  David Pyring ,  Can Slivo ,  David Wensbo

    发明人： Michaela Vallin ,  Jonas Malmstrom ,  David Pyring ,  Can Slivo ,  David Wensbo

    IPC分类号： A61K51/04 ,  A61K31/5377 ,  A61K31/496 ,  A61K31/437 ,  C07D413/14 ,  C07D401/14 ,  C07D471/04 ,  A61P25/28 ,  A61K49/00 ,  A61K49/10

    CPC分类号： C07D471/04 ,  A61K49/10 ,  A61K51/041 ,  A61K51/0453 ,  A61K51/0455 ,  A61K51/0459 ,  A61K51/0463

    摘要： The present invention relates to novel heteroaryl substituted imidazopyridine derivatives, precursors thereof, and therapeutic uses of such compounds, having the structural formula (Ia) and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel heteroaryl substituted imidazopyridine derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measuring clinical efficacy of Alzheimer's disease therapeutic agents.

    摘要翻译： 本发明涉及新颖的杂芳基取代的咪唑并吡啶衍生物，其前体和具有结构式（Ia）的这类化合物及其药学上可接受的盐，组合物和使用方法的治疗用途。 此外，本发明涉及适用于在活体患者中成像淀粉样蛋白沉积物的新型杂芳基取代的咪唑并吡啶衍生物，其组合物，使用方法和制备此类化合物的方法。 更具体地说，本发明涉及一种在体内淀粉样蛋白沉积物在体内成像以使阿尔茨海默病的止血诊断成为可能并测量阿尔茨海默病治疗剂的临床疗效的方法。